Treatment of recurrent follicular lymphoma

摘要

Methods for treating follicular lymphoma (FL) in subjects experiencing the progression of early disease after immunochemotherapy using phosphoinositide 3-kinase (PI3K) inhibitors are provided herein.In a particular embodiment, the method comprises the use of a phosphoinositide 3-kinase (PI3K) inhibitor to treat FL in a subject experiencing the progression of disease within 24 months of initiation of primary or subsequent immunochemotherapy.Diagram